APR 05, 2017 07:15 AM PDT

Optimizing homology-directed repair (HDR) results with CRISPR-Cas9

Speakers
  • Research Scientist at Dharmacon, part of GE Healthcare
    Biography
      John Schiel is a research scientist at Dharmacon, part of GE Healthcare. He joined the R&D team at Dharmacon in 2014 and is actively involved in developing research tools within the gene modulation and genome editing fields of research which include RNA interference (http://dharmacon.gelifesciences.com/rnai-and-custom-rna-synthesis/) and CRISPR-Cas9 genome engineering (http://dharmacon.gelifesciences.com/gene-editing/crispr-cas9/) He received his Bachelor of Science degree in Biochemistry at Colorado State University and his Ph.D. degree in Cell Biology at the University of Colorado Denver - Anschutz Medical Campus. John completed a postdoctoral fellowship at University of Massachusetts Medical School where he studied asymmetric cell division and centrosome maturation.

    Abstract:

    CRISPR-Cas9 has increased the accessibility of genome engineering due to its ease of use and ability to cause double strand breaks (DSBs) at almost any locus of interest. DSBs are repaired in cells by two predominant pathways: non-homologous end joining (NHEJ) and homology-directed repair (HDR). Endogenous repair of DSBs using the NHEJ pathway typically results in functional protein disruption (knockout) whereas the HDR pathway can be used to introduce exogenous genetic content (knockin). During this webinar we will focus on the utility of a synthetic dual RNA approach to apply CRISPR-Cas9 to HDR genomic engineering applications and will provide guidelines for improving CRISPR Cas9-assisted HDR. We will also discuss the use of short single-stranded DNA as a donor template for small insertions as well as plasmid DNA donor templates for large insertions. Lastly, we outline methods for characterization of HDR-generated cell lines for precise genomic engineering.


    Show Resources
    You May Also Like
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JAN 23, 2020 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JAN 23, 2020 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: TIME: adadf adfadf...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    NOV 18, 2019 07:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    FEB 26, 2020 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 26, 2020 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    Loading Comments...
    Show Resources